385 related articles for article (PubMed ID: 27087491)
1. Lipid Nanoparticles and their Application in Nanomedicine.
Rajabi M; Mousa SA
Curr Pharm Biotechnol; 2016; 17(8):662-72. PubMed ID: 27087491
[TBL] [Abstract][Full Text] [Related]
2. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems.
Keck CM; Müller RH
Eur J Pharm Biopharm; 2013 Aug; 84(3):445-8. PubMed ID: 23333302
[TBL] [Abstract][Full Text] [Related]
3. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
4. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
Farjadian F; Ghasemi A; Gohari O; Roointan A; Karimi M; Hamblin MR
Nanomedicine (Lond); 2019 Jan; 14(1):93-126. PubMed ID: 30451076
[TBL] [Abstract][Full Text] [Related]
5. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
6. Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications.
Dave V; Tak K; Sohgaura A; Gupta A; Sadhu V; Reddy KR
J Microbiol Methods; 2019 May; 160():130-142. PubMed ID: 30898602
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.
Kathe N; Henriksen B; Chauhan H
Drug Dev Ind Pharm; 2014 Dec; 40(12):1565-75. PubMed ID: 24766553
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
9. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
11. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
12. High melting lipid based approach for drug delivery: solid lipid nanoparticles.
Kumar S; Randhawa JK
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1842-52. PubMed ID: 23498204
[TBL] [Abstract][Full Text] [Related]
13. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
14. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
15. A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine.
Jahangirian H; Lemraski EG; Webster TJ; Rafiee-Moghaddam R; Abdollahi Y
Int J Nanomedicine; 2017; 12():2957-2978. PubMed ID: 28442906
[TBL] [Abstract][Full Text] [Related]
16. A critical review of lipid-based nanoparticles for taxane delivery.
Feng L; Mumper RJ
Cancer Lett; 2013 Jul; 334(2):157-75. PubMed ID: 22796606
[TBL] [Abstract][Full Text] [Related]
17. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.
Mildner R; Hak S; Parot J; Hyldbakk A; Borgos SE; Some D; Johann C; Caputo F
Eur J Pharm Biopharm; 2021 Jun; 163():252-265. PubMed ID: 33745980
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
19. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]